Biodesix posts $8.84M loss in first earnings as public company
BOULDER — Biodesix Inc. (Nasdaq: BDSX) lost $8.84 million in the third quarter of 2020, a period where the company […]
Source: BizWest
Related Articles
BizWest celebrates 40 years covering business and recognizes 40 iconic leaders who inspired the region’s development.
View related stories: Click here to view the 40th Anniversary supplement. ‘Turnpike’ helps define how economy has changed Wood: Preserving…
Biodesix losses grow with pivot from COVID-19 testing
BOULDER — Biodesix Inc. (Nasdaq: BDSX), a life-sciences company that specializes in developing tools to detect lung disease, saw its…
Biodesix expects significant sales growth in third quarter
BOULDER — Biodesix Inc. (Nasdaq: BDSX), a Boulder-headquartered life-sciences company that specializes in developing tools to detect lung disease, is…
Biodesix offers new shares to bolster credit line
BOULDER — Biodesix Inc. (Nasdaq: BDSX), a life-sciences company that specializes in developing tools to detect lung disease, has launched…
Biodesix posts $13.7M net loss in third quarter
BOULDER — Biodesix Inc. (Nasdaq: BDSX), a lung-diagnostics company, reported a $13.7 million loss for the third quarter of 2022. …